MEDIBANK PRIVATE LIMITED (MPL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MPL - MEDIBANK PRIVATE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Medibank Private is the largest Australian private health insurance provider. Previously an Australian Government business enterprise, established by the Whitlam government in 1975, it was privatised in 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.31

29 Jul
2021

-0.020

OPEN

$3.30

-0.60%

HIGH

$3.33

0

LOW

$3.28

TARGET
$3.213 -2.9% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AMP . IAG . ISU . NHF . QBE . SDF . SUN . TWR . CVW . GDG . PSI . FCL .
FNARENA'S MARKET CONSENSUS FORECASTS
MPL: 1
Title FY19
Actual
FY20
Actual
FY21
Forecast
FY22
Forecast
EPS (cps) xxx 11.4 15.5 xxx
DPS (cps) xxx 12.0 12.4 xxx
EPS Growth xxx - 31.3% 35.2% xxx
DPS Growth xxx - 23.1% 3.0% xxx
PE Ratio xxx N/A 21.4 xxx
Dividend Yield xxx N/A 3.7% xxx
Div Pay Ratio(%) xxx 104.9% 79.9% xxx

Dividend yield today if purchased 3 years ago: 3.86%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.63

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 03/03 - 5.8c (100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201520162017201820192020
EPS Basic xxxxxxxxxxxxxxx11.4
DPS All xxxxxxxxxxxxxxx12.0
Sales/Revenue xxxxxxxxxxxxxxx6,832.4 M
Book Value Per Share xxxxxxxxxxxxxxx65.9
Net Operating Cash Flow xxxxxxxxxxxxxxx600.2 M
Net Profit Margin xxxxxxxxxxxxxxx4.62 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

30/06/2021

3

Hold

$3.15

(21/07/2021)

-4.83%

Medibank Private will assess if any more savings need to be returned, after announcing it will return -$105m in estimated permanent net covid claims savings to customers in FY22. This will be achieved by providing premium relief for those who held a policy in FY21.

Ord Minnett points out this is roughly equivalent to 1.5% of a year's premium versus the deferred claims liability at December 31 of $310m. It's felt the return is both a retention initiative and designed to be fair to existing customers.

The Hold rating and $3 target price are unchanged.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

FORECAST
Ord Minnett forecasts a full year FY21 dividend of 12.00 cents and EPS of 16.00 cents.
Ord Minnett forecasts a full year FY22 dividend of 12.00 cents and EPS of 15.00 cents.

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

(xx/xx/xxxx)

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

MPL STOCK CHART